Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are older than 16 years of age
- You have active vasculitis (inflammation of the blood vessels) that is either newly diagnosed or has come back after a period of improvement
- You have been diagnosed with IgA vasculitis (a type of blood vessel inflammation linked to a protein called IgA)
- You have been diagnosed with ANCA vasculitis (a type of blood vessel inflammation linked to certain antibodies in the blood)
- You have been diagnosed with Giant cell arteritis (a type of inflammation affecting larger blood vessels, often in the head)
Who may not be able to join:
- You have asked for your personal data not to be used or processed
- You are currently pregnant
- You have tested positive for HIV, Hepatitis B (HBV), or Hepatitis C (HCV)
- You have been treated with steroids, drugs that suppress the immune system, or biological therapies in the past month
- You are unable to read or understand the information leaflet provided about the trial
- You are an adult who is under legal guardianship or supervised protection (confirm with trial site)
⚠️ Important: Always verify eligibility with the trial site directly before applying. This information is provided to help you understand the trial criteria only and is not medical advice. A healthcare professional or the trial team must assess whether this trial is right for you.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 02 47 47 37 15
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
cytokine/chemokine/metabolite concentrations; cytokine/chemokine/metabolite concentrations; cytokine/chemokine/metabolite concentrations; cytokine/chemokine/metabolite concentrations; cytokine/chemokine/metabolite concentrations; percentage of different non-conventional T cell populations; percentage of different non-conventional T cell populations; percentage of different non-conventional T cell populations; percentage of different non-conventional T cell populations; percentage of different non-conventional T cell populations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.